Form 8-K - Current report:
SEC Accession No. 0001157523-08-004016
Filing Date
2008-05-08
Accepted
2008-05-08 16:19:55
Documents
2
Period of Report
2008-05-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 ALNYLAM PHARMACEUTICALS, INC. 8-K a5679827.htm 8-K 19340
2 EXHIBIT 99.1 a5679827ex99_1.htm EX-99.1 68497
  Complete submission text file 0001157523-08-004016.txt   89473
Mailing Address 300 THIRD STREET CAMBRIDGE MA 02142
Business Address 300 THIRD STREET CAMBRIDGE MA 02142 (617) 551-8200
ALNYLAM PHARMACEUTICALS, INC. (Filer) CIK: 0001178670 (see all company filings)

EIN.: 770602661 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50743 | Film No.: 08814291
SIC: 2834 Pharmaceutical Preparations